Indeed, ClC-3 is regarded as a sign of poor prognosis in GC, and high expression of ClC-3 is significantly related to tumor aggressiveness, lymph node metastasis, and overall survival of patients with GC. This evidence concerns the gene CLCN3 and metastatic malignant neoplasm in the lymph nodes.